✦ LIBER ✦
Can molecular biomarker-based patient selection in Phase I trials accelerate anticancer drug development?
✍ Scribed by Craig P. Carden; Debashis Sarker; Sophie Postel-Vinay; Timothy A. Yap; Gerthardt Attard; Udai Banerji; Michelle D. Garrett; George V. Thomas; Paul Workman; Stan B. Kaye; Johann S. de Bono
- Book ID
- 113569071
- Publisher
- Elsevier Science
- Year
- 2010
- Tongue
- English
- Weight
- 856 KB
- Volume
- 15
- Category
- Article
- ISSN
- 1359-6446
No coin nor oath required. For personal study only.